Author

T. R. Kreil

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Approach:experimental assay· 3 Assay:proteomics· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:statistical model· 1

Frequent Co-Authors

M. Karbiener· 3 shared M. R. Farcet· 3 shared J. Schwaiger· 2 shared A. Adonyi· 1 shared A.-D. Gorki· 1 shared C. Aberham· 1 shared C. Jungbauer· 1 shared D. Blaas· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

M. Karbiener

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Host-directed therapy with 2-Deoxy-D-glucose inhibits human rhinoviruses, endemic coronaviruses, and SARS-CoV-2

L. Wali, M. Karbiener, S. Chou, V. Kovtunyk, A. Adonyi, I. Goesler, X. Contreras, D. Stoeva, D. Blaas, J. Stoeckl, T. R. Kreil, G. A. Gualdoni, A.-D. Gorki

This study shows 2-deoxy-D-glucose inhibits replication of rhinoviruses, endemic coronaviruses, and SARS-CoV-2 in epithelial cells by disrupting viral RNA synthesis and reducing viral load.

bioRxiv · May 24, 2022Microbiology

Rapidly Increasing SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced from Plasma Collected During the 2020 Pandemic

M. R. Farcet, M. Karbiener, J. Schwaiger, R. Ilk, T. R. Kreil

The paper analyzes SARS-CoV-2 neutralizing antibody levels in intravenous immunoglobulins (IG) collected during the 2020 pandemic, showing increasing potency over time.

bioRxiv · Feb 12, 2021Immunology

No SARS-CoV-2 cross-neutralization by intravenous immunoglobulins produced from plasma collected before the 2020 pandemic

J. Schwaiger, M. Karbiener, C. Aberham, M. R. Farcet, T. R. Kreil

The paper tests 54 intravenous immunoglobulin preparations from pre-pandemic plasma and finds they neutralize seasonal coronavirus hCoV-229E but not SARS-CoV-2.

bioRxiv · Jul 30, 2020Immunology

Characterization of 100 sequential SARS-CoV-2 convalescent plasma donations

C. Jungbauer, L. Weseslindtner, L. Weidner, S. Gaensdorfer, M. R. Farcet, E. Gschaider-Reichhart, T. R. Kreil

The paper characterizes 100 sequential SARS-CoV-2 convalescent plasma donations to assess neutralizing antibody content and identify donor characteristics for more potent plasma collection.

bioRxiv · Jun 21, 2020Immunology